{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:24:02Z","timestamp":1793298242276,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["24DX2800100"],"award-info":[{"award-number":["24DX2800100"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.mtbio.2025.102148","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:14:24Z","timestamp":1753683264000},"page":"102148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Organoid-on-a-chip (OrgOC): Advancing cystic fibrosis research"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-0570","authenticated-orcid":false,"given":"Minjie","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Erice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1796-1804","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8882-1131","authenticated-orcid":false,"given":"Charles H.","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.102148_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2025.102148_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2025.102148_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-05854-7","article-title":"CFTR function, pathology and pharmacology at single-molecule resolution","volume":"616","author":"Levring","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102148_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic fibrosis modulator therapies","volume":"74","author":"Jia","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib6","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","author":"Hill","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mtbio.2025.102148_bib7","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2025.102148_bib8","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41598-019-42404-6","article-title":"Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools","volume":"9","author":"Pereira","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2025.102148_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mtbio.2025.102148_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/j.1572-0241.2000.02244.x","article-title":"A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency","volume":"95","author":"Stern","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.mtbio.2025.102148_bib11","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.mtbio.2025.102148_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.121.1.55","article-title":"Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis","volume":"121","author":"Moss","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.mtbio.2025.102148_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation power in cystic fibrosis oatients: the eager trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/ajrccm.153.5.8630593","article-title":"Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis","volume":"153","author":"Robinson","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prrv.2007.02.008","article-title":"Other mucoactive agents for cystic fibrosis","volume":"8","author":"Bye","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.mtbio.2025.102148_bib16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(23)01608-2","article-title":"The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches","volume":"402","author":"Graeber","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2025.102148_bib17","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2025.102148_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion channel modulators in cystic fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.mtbio.2025.102148_bib19","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2025.102148_bib20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib21","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S2213-2600(23)00324-7","article-title":"Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy","volume":"11","author":"Hisert","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.chest.2021.11.001","article-title":"Emerging nonpulmonary complications for adults with cystic fibrosis","volume":"161","author":"Chin","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.mtbio.2025.102148_bib25","article-title":"Exon-skipping antisense oligonucleotides for cystic fibrosis therapy","volume":"119","author":"Kim","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2025.102148_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007723","article-title":"Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis","volume":"14","author":"Sharma","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mtbio.2025.102148_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/17476348.2016.1162715","article-title":"Infection in cystic fibrosis: impact of the environment and climate","volume":"10","author":"Ramsay","year":"2016","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/17476348.2020.1753507","article-title":"Influences of environmental exposures on individuals living with cystic fibrosis","volume":"14","author":"Szczesniak","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-genom-083117-021329","article-title":"Cystic fibrosis disease modifiers: complex genetics defines the phenotypic diversity in a monogenic disease","volume":"19","author":"O'Neal","year":"2018","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.mtbio.2025.102148_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12967-021-03099-4","article-title":"Gene therapy for cystic fibrosis: new tools for precision medicine","volume":"19","author":"Lee","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00228013","article-title":"CFTR: cystic fibrosis and beyond","volume":"44","author":"Mall","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-pathol-022420-105133","article-title":"Animal models and their role in understanding the pathophysiology of cystic fibrosis\u2013associated gastrointestinal lesions","volume":"16","author":"Gibson-Corley","year":"2021","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.mtbio.2025.102148_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcf.2004.05.040","article-title":"Established cell lines used in cystic fibrosis research","volume":"3","author":"Gruenert","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib34","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc23-0380","article-title":"Cystic fibrosis\u2013related diabetes workshop: research priorities spanning disease pathophysiology, diagnosis, and outcomes","volume":"46","author":"Putman","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mtbio.2025.102148_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102148_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mtbio.2025.102148_bib38","article-title":"Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function","volume":"52","author":"Groot","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170500","article-title":"Recent advances in lung organoid development and applications in disease modeling","volume":"133","author":"Vazquez-Armendariz","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mtbio.2025.102148_bib40","first-page":"958","article-title":"Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish","volume":"144","author":"McCauley","year":"2017","journal-title":"Dev. Camb. Engl."},{"key":"10.1016\/j.mtbio.2025.102148_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2020.11.009","article-title":"Organ-on-a-Chip: a new paradigm for drug development","volume":"42","author":"Ma","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib42","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1021\/acs.analchem.1c04641","article-title":"Human spinal Organoid-on-a-Chip to model nociceptive circuitry for pain therapeutics discovery","volume":"94","author":"Ao","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mtbio.2025.102148_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401843","article-title":"Organoids-on-a-chip for personalized precision medicine","volume":"13","author":"Man","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.mtbio.2025.102148_bib44","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1039\/D1LC00011J","article-title":"Retinal organoids on-a-chip: a micro-millifluidic bioreactor for long-term organoid maintenance","volume":"21","author":"Xue","year":"2021","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.102148_bib45","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7150\/thno.90492","article-title":"Human organoids-on-chips for biomedical research and applications","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2025.102148_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.aaw7894","article-title":"Organoids-on-a-chip","volume":"364","author":"Park","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2025.102148_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-pharmtox-010818-021108","article-title":"Organoids for drug discovery and personalized medicine","volume":"59","author":"Takahashi","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mtbio.2025.102148_bib48","article-title":"Engineering placenta\u2010like organoids containing endogenous vascular cells from human\u2010induced pluripotent stem cells","volume":"8","author":"Cui","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajpath.2020.10.017","article-title":"Animal and cell culture models for cystic fibrosis","volume":"191","author":"McCarron","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mtbio.2025.102148_bib50","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","article-title":"Rectal organoids enable personalized treatment of cystic fibrosis","volume":"26","author":"Berkers","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.mtbio.2025.102148_bib51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41551-019-0397-0","article-title":"A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip","volume":"3","author":"Jalili-Firoozinezhad","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2025.102148_bib52","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2025.102148_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcf.2021.10.004","article-title":"Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip\u5728\u82af\u7247\u4e0a\u6a21\u62df\u4eba\u80ba\u6c14\u9053\u4e2d\u7684\u80ba\u56ca\u6027\u7ea4\u7ef4\u5316","volume":"21","author":"Plebani","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102148_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature09941","article-title":"Self-organizing optic-cup morphogenesis in three-dimensional culture","volume":"472","author":"Eiraku","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102148_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol.J Hematol Oncol"},{"key":"10.1016\/j.mtbio.2025.102148_bib57","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2022.11.007","article-title":"Patient-derived cell models for personalized medicine approaches in cystic fibrosis","volume":"22","author":"Ramalho","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib58","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","article-title":"Long\u2010term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.mtbio.2025.102148_bib59","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jcf.2019.11.002","article-title":"Intestinal organoids for cystic fibrosis research","volume":"19","author":"de Poel","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib60","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1038\/s41467-022-31854-8","article-title":"A multimodal iPSC platform for cystic fibrosis drug testing","volume":"13","author":"Berical","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102148_bib61","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.molmed.2018.06.009","article-title":"Pluripotent stem cell platforms for drug discovery","volume":"24","author":"Chen","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib62","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2025.102148_bib63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib64","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1073\/pnas.1806308115","article-title":"Differentiated human airway organoids to assess infectivity of emerging influenza virus","volume":"115","author":"Zhou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2025.102148_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcf.2019.10.022","article-title":"Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations","volume":"19","author":"De Winter \u2013 De Groot","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jcf.2024.04.014","article-title":"Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with cystic fibrosis","volume":"23","author":"Bierlaagh","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib67","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2023.03.004","article-title":"FDA-Approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes","volume":"22","author":"de Poel","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810377","article-title":"Evaluation of the complex p.[Leu467Phe;Phe508del] CFTR allele in the intestinal organoids model: implications for therapy","volume":"23","author":"Kondratyeva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib69","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02426-2019","article-title":"Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis","volume":"57","author":"Ramalho","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012657","article-title":"Drug repurposing for cystic fibrosis: identification of drugs that induce CFTR-independent fluid secretion in nasal organoids","volume":"23","author":"Rodenburg","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib71","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/23120541.00495-2022","article-title":"High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing","volume":"9","author":"Spelier","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.mtbio.2025.102148_bib72","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1183\/13993003.01661-2015","article-title":"\u03b22-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis","volume":"48","author":"Vijftigschild","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2018.02.007","article-title":"Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity","volume":"17","author":"Zomer-van Ommen","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcf.2015.07.007","article-title":"Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids","volume":"15","author":"Zomer-van Ommen","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/13993003.01192-2015","article-title":"Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids","volume":"48","author":"Dekkers","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210358","article-title":"Theratyping of the rare CFTR genotype A559T in rectal organoids and nasal cells reveals a relevant response to elexacaftor (VX-445) and tezacaftor (VX-661) combination","volume":"24","author":"Kleinfelder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib77","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gutjnl-2016-312423","article-title":"Human pluripotent stem cell-derived acinar\/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling","volume":"66","author":"Hohwieler","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.mtbio.2025.102148_bib78","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.3390\/ijms24076293","article-title":"Airway and lung organoids from human-induced pluripotent stem cells can be used to assess CFTR conductance","volume":"24","author":"Demchenko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omtm.2021.11.008","article-title":"The sodium\/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay","volume":"24","author":"Hirai","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.mtbio.2025.102148_bib80","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00639.2020","article-title":"CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling","volume":"321","author":"Anderson","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.mtbio.2025.102148_bib81","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/genes11060603","article-title":"Human nasal epithelial organoids for therapeutic development in cystic fibrosis","volume":"11","author":"Liu","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.mtbio.2025.102148_bib82","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00908-2021","article-title":"Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells","volume":"58","author":"Sette","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib83","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00508-2021","article-title":"Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression","volume":"60","author":"Muilwijk","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib84","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201857","article-title":"Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis","volume":"6","author":"Birimberg-Schwartz","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.mtbio.2025.102148_bib85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2021.07.006","article-title":"Response to elexacaftor\/tezacaftor\/ivacaftor in intestinal organoids derived from people with cystic fibrosis","volume":"21","author":"Furstova","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib86","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1164\/rccm.201505-0914OC","article-title":"rAAV-CFTR\u0394R rescues the cystic fibrosis phenotype in human intestinal organoids and cystic fibrosis mice","volume":"193","author":"Vidovi\u0107","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mtbio.2025.102148_bib88","first-page":"326","article-title":"The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis","volume":"40","author":"Clarke","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mtbio.2025.102148_bib89","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/cells10123419","article-title":"High-throughput functional analysis of CFTR and other apically localized proteins in iPSC-Derived human intestinal organoids","volume":"10","author":"Xia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2025.102148_bib90","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/ijms26020437","article-title":"Human induced lung organoids: a promising tool for cystic fibrosis drug screening","volume":"26","author":"Demchenko","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib91","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.3390\/ijms24065199","article-title":"CFTR modulators rescue the activity of CFTR in colonoids expressing the complex allele","volume":"24","author":"Kleinfelder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib92","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcf.2014.10.007","article-title":"A bioassay using intestinal organoids to measure CFTR modulators in human plasma","volume":"14","author":"Dekkers","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib93","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00038.2023","article-title":"The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators","volume":"324","author":"Chen","year":"2023","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.mtbio.2025.102148_bib94","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jcf.2022.01.008","article-title":"Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype","volume":"21","author":"Aalbers","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib95","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcf.2020.04.014","article-title":"Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation","volume":"19","author":"Berkers","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib96","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jcf.2021.12.006","article-title":"Rescue of chloride and bicarbonate transport by elexacaftor-ivacaftor-tezacaftor in organoid-derived CF intestinal and cholangiocyte monolayers","volume":"21","author":"Bijvelds","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcf.2024.09.005","article-title":"Gene expression profile of intestinal organoids from people with cystic fibrosis upon exposure to elexacaftor\/tezacaftor\/ivacaftor","volume":"24","author":"Cinek","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib98","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcf.2021.01.009","article-title":"Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids","volume":"20","author":"Crawford","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib99","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/ijms25052770","article-title":"Comprehensive assessment of CFTR modulators' therapeutic efficiency for N1303K variant","volume":"25","author":"Efremova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/cells9030754","article-title":"Phenotyping of rare CFTR mutations reveals distinct trafficking and functional defects","volume":"9","author":"Ensinck","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2025.102148_bib101","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/cells11152295","article-title":"Absence of EPAC1 signaling to stabilize CFTR in intestinal organoids","volume":"11","author":"Ferreira","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2025.102148_bib102","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.omtm.2020.04.005","article-title":"iPSC-Derived intestinal organoids from cystic fibrosis patients acquire CFTR activity upon TALEN-mediated repair of the p.F508del mutation","volume":"17","author":"Fleischer","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.mtbio.2025.102148_bib103","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","article-title":"CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank","volume":"26","author":"Geurts","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.mtbio.2025.102148_bib104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcf.2024.09.019","article-title":"Elexacaftor\/tezacaftor\/ivacaftor efficacy in intestinal organoids with rare CFTR variants in comparison to CFTR-F508del and CFTR-wild type controls","volume":"24","author":"Kroes","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914539","article-title":"CFTR function restoration upon Elexacaftor\/tezacaftor\/ivacaftor treatment in patient-derived intestinal organoids with rare CFTR genotypes","volume":"24","author":"Lefferts","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib106","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jcf.2023.04.003","article-title":"Targeted locus amplification reveals heterogeneity between and within CFTR genotypes and association with CFTR function in patient-derived intestinal organoids","volume":"22","author":"Lefferts","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib107","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-019-11454-9","article-title":"Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing","volume":"10","author":"Maule","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102148_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2025.01.015","article-title":"Personalized therapy with CFTR modulators: response of p.Ile148Asn variant CFTR","author":"Rodrigues","year":"2025","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102148_bib109","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.mtbio.2025.102148_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165905","article-title":"Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: the case of S955P and 1717\u20132A>G","volume":"1866","author":"Silva","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.mtbio.2025.102148_bib111","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcf.2020.02.001","article-title":"R117H-CFTR function and response to VX-770 correlate with mRNA and protein expression in intestinal organoids","volume":"19","author":"Van Mourik","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1165\/rcmb.2021-0337OC","article-title":"Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defect","volume":"67","author":"Wong","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.mtbio.2025.102148_bib113","article-title":"Molecular dynamics and functional characterization of I37R-CFTR lasso mutation provide insights into channel gating activity","volume":"25","author":"Wong","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.mtbio.2025.102148_bib114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jcf.2018.07.001","article-title":"R560S: a class II CFTR mutation that is not rescued by current modulators","volume":"18","author":"Awatade","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib115","article-title":"Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells, cell rep","volume":"5","author":"Bulcaen","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.mtbio.2025.102148_bib116","first-page":"343","article-title":"CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids, orphanet J","volume":"19","author":"Kleinfelder","year":"2024","journal-title":"Rare Dis."},{"key":"10.1016\/j.mtbio.2025.102148_bib117","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01341-2022","article-title":"Rectal organoid-guided CFTR modulator therapy restores lung function in a cystic fibrosis patient with the rare 1677delTA\/R334W genotype","volume":"60","author":"Mitropoulou","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mtbio.2025.102148_bib118","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12931-023-02516-0","article-title":"L1077P CFTR pathogenic variant function rescue by Elexacaftor\u2013Tezacaftor\u2013Ivacaftor in cystic fibrosis patient-derived air\u2013liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients","volume":"24","author":"Lo Cicero","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.mtbio.2025.102148_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011559","article-title":"Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids","volume":"19","author":"Leon-Icaza","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mtbio.2025.102148_bib120","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s41598-024-82500-w","article-title":"Dual RNA sequencing of a co-culture model of Pseudomonas aeruginosa and human 2D upper airway organoids","volume":"15","author":"Pleguezuelos-Manzano","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2025.102148_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.131962","article-title":"Sentinel supervised lung-on-a-chip: a new environmental toxicology platform for nanoplastic-induced lung injury","volume":"458","author":"Yang","year":"2023","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.mtbio.2025.102148_bib122","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcf.2021.10.004","article-title":"Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip","volume":"21","author":"Plebani","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.mtbio.2025.102148_bib123","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acsbiomaterials.2c01460","article-title":"Easy-to-Build and reusable microfluidic device for the dynamic culture of human bronchial cystic Fibrosis Epithelia","volume":"9","author":"Mazio","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.mtbio.2025.102148_bib124","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4634","article-title":"Pancreatic pathophysiology in cystic fibrosis","volume":"238","author":"Gibson-Corley","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.mtbio.2025.102148_bib125","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1038\/s41467-019-11178-w","article-title":"Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders","volume":"10","author":"Mun","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102148_bib126","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1039\/D0LC00644K","article-title":"A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases","volume":"20","author":"Mej\u00edas","year":"2020","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.102148_bib127","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s44222-024-00207-z","article-title":"Integrating organoids and organ-on-a-chip devices","volume":"2","author":"Zhao","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.mtbio.2025.102148_bib128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrm.2017.108","article-title":"Mechanical forces direct stem cell behaviour in development and regeneration","volume":"18","author":"Vining","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mtbio.2025.102148_bib129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2022.10.001","article-title":"Microfluidic organoids-on-a-chip: the future of human models","volume":"144","author":"Saorin","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.mtbio.2025.102148_bib130","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1039\/C8LC00910D","article-title":"Human stomach-on-a-chip with luminal flow and peristaltic-like motility","volume":"18","author":"Lee","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.102148_bib131","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1039\/C8LC01298A","article-title":"Engineering human islet organoids from iPSCs using an organ-on-chip platform","volume":"19","author":"Tao","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.102148_bib132","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2025.102148_bib133","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1039\/D1LC00535A","article-title":"Engineering neurovascular organoids with 3D printed microfluidic chips","volume":"22","author":"Salmon","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.102148_bib134","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1039\/C8LC00596F","article-title":"Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids","volume":"18","author":"Shirure","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.102148_bib135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1073\/pnas.1417115112","article-title":"Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation","volume":"112","author":"Jeon","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mtbio.2025.102148_bib136","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","article-title":"A microfluidic platform integrating functional vascularized organoids-on-chip","volume":"15","author":"Quintard","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102148_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202402431","article-title":"Lubricant-coated organ-on-a-chip for enhanced precision in preclinical drug testing","volume":"20","author":"Kim","year":"2024","journal-title":"Small"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425007185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425007185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:00:57Z","timestamp":1757959257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425007185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":137,"alternative-id":["S2590006425007185"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102148","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoid-on-a-chip (OrgOC): Advancing cystic fibrosis research","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102148"}}